Transforming Cancer Care Through Genomics
At Anuvansh, we believe that cancer is not a one-size-fits-all disease, and neither should its treatment be. Our approach to precision oncology harnesses the power of genomics, transcriptomics, and biomarker data to deliver personalized, data-driven cancer care. From inherited risk assessment to real-time tumor profiling, we combine the latest scientific discoveries with clinical utility.
We integrate insights from comprehensive DNA/RNA sequencing, multi-gene panels, epigenetic profiling, and computational analytics to select targeted therapies and support tumor-agnostic approaches.
We work at the intersection of clinic and computation, linking cancer biology with scalable AI tools, digital health infrastructure, and personalized therapeutic insights.
Oncology Offerings at Anuvansh:
Genomic Risk & Prevention
- Multigene panel testing to assess hereditary cancer risk (e.g., BRCA1/2, Lynch syndrome)
- Polygenic risk scoring for complex risk stratification
- Germline variant analysis for early detection and preventive planning
- Personalized surveillance and screening pathways for high-risk individuals
- Family-based cascade testing and genetic counseling support
Tumor Characterization & Subtyping
- Tumor-agnostic mutation detection (e.g., NTRK, MSI-H, TMB) to guide immunotherapy and targeted treatment
- Biomarker integration (e.g., PD-L1, HER2, BRAF) for prognosis and therapy alignment
Therapy Matching & Monitoring
- Precision treatment selection for approved and investigational targeted therapies such as EGFR/ALK inhibitors in lung cancer, PARP inhibitors in BRCA-mutant tumors, HER2-directed treatment in breast and gastric cancers
- Tumor-agnostic therapy support using actionable alterations across cancer types
- Real-time integration of genomics and EHR data to optimize care plans
Interpretation, Reporting & Clinomics
- Expert-driven variant interpretation including VUS resolution
- Use of AI-assisted pipelines and curated knowledge bases for annotation
- Clinomics Dashboards integrating genomic, clinical, and lab data for oncologists
- Data visualization and decision-support tools to improve patient-provider communication